Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1868 of 6351
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control OngoingThe main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can airway shape predict sleep apnea severity?
Knowledge-focused CompletedSleep apnea-hypopnea syndrome (SAHS) is a disorder of nocturnal ventilation due to the occurrence abnormally frequent pauses in breathing. It is a public health problem that currently affects 13 % of men and 6% of women between 30 and 70 years old. Sleep apneas are conventionally…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could 4-minute workouts boost teen brainpower?
Symptom relief CompletedThe study suggests that the high intensity exercise training program is beneficial for the female teenagers to enhance their cognitive abilities along with the physical strengthening. It also helps the teenagers to increase their mental health for better health and memory.
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Heart drug may keep AFib away after ablation in seniors
Disease control CompletedStudy name: Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation. Medicine: sacubitril/valsartan (100mg) and valsartan (80mg). Rationale: The latest guidelines represent an intensified …
Phase 4 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Precision radiation boost aims to improve prostate cancer treatment
Disease control OngoingThis is a single-arm feasibility study that is recruiting 40 patients with histologically-proven localized prostate cancer and MRI-defined lesion(s). Participants in this study will get MR-guided radiotherapy boost to MRI visible tumour before or after whole gland radiation. Part…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Breath sniffing may reveal early clues to cystic fibrosis drug success
Knowledge-focused CompletedThis study relies on the hypotheses that (1) exhaled breath is intimately correlated to the patient's lung condition and that (2)the composition of exhaled breath , i.e. the VOCs profile, will be significantly modified from the first days of treatment by CFTR modulators in a or p…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can a common ADHD drug truly sharpen a healthy mind? a trial puts it to the test
Knowledge-focused CompletedThis study evaluated the effects of methylphenidate (MPH), a stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD), in healthy adults without ADHD. Although MPH is sometimes used by students and athletes to improve concentration or performanc…
Early phase 1 • Sponsor: University of Witwatersrand, South Africa • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can threads or plasma smooth out old scars?
Disease control CompletedThis study compares the efficacy and safety of poly-L-lactic acid (PLLA) threads versus platelet-rich plasma (PRP), both combined with subcision, in the treatment of post-traumatic atrophic scars. Patients with post-traumatic atrophic scars were allocated to either a single sessi…
Sponsor: Tanta University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New pill shows promise for Diabetes-Related vision loss
Disease control CompletedThe objective of this trial is to assess the safety, efficacy, and tolerability of RZ402 in patients with Diabetic Macular Edema.
Phase 2 • Sponsor: Rezolute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can Anti-Diarrhea meds make a powerful breast cancer drug safer?
Disease control CompletedThis is a multicenter, open-label, single-arm, multicohort, two-stage optimal Simon's design, phase II clinical trial that is designed to improve the tolerance of sacituzumab govitecan in patients with unresectable locally advanced or metastatic triple negative breast cancer (TNB…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New flu vaccine for toddlers shows promise in large trial
Vaccine CompletedA random, blind and positive control design was adopted.the investigators will assess the safety and immunogenicity of 2 doses of an quadrivalent influenza vaccine virus subunit in children aged 6 to 35 months. A total of 2,772 subjects in the 6-35 month age group were randomly …
Phase 3 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: Vaccine
Last updated Jun 27, 2026 08:08 UTC
-
New hope for rare eye disease: personalized drug schedule shows promise
Disease control CompletedThis study is a 60-week, two-arm, randomized, open-label, active-controlled, multi-center study in patients with Polypoidal choroidal vasculopathy (PCV) who have not previously received anti-Vascular endothelial growth factor (VEGF) treatment.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New pill targets rare genetic cancers in first human trial
Disease control OngoingThis is a Phase 1/1b, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary antineoplastic activity of APS03118 administered orally in participants with RET-altered solid tumors.
Phase 1 • Sponsor: Applied Pharmaceutical Science, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New nasal spray vaccine for RSV shows promise in young children
Vaccine CompletedThe primary purpose of the study is to assess the shedding, transmission, and genetic stability of the live-attenuated RSVt vaccine after each intranasal vaccination (56 days apart) in infants and toddlers 6 to \< 24 months of age.
Phase 1/2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 08:14 UTC
-
Could a salad ingredient help treat diabetes? new trial underway
Disease control Recruiting nowBlood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. …
Phase 2 • Sponsor: Housey Healthcare ULC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for failed Weight-Loss surgery: simpler bypass shows promise
Disease control Recruiting nowSleeve gastrectomy (SG) has become the most commonly performed weight loss surgery, accounting for 60% of all bariatric operations worldwide. While technically easier with less side-effects and nutritional risks than other operations, SG is also associated with a higher risk of f…
Sponsor: Laval University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug trial aims to ease skin hardening in rare autoimmune disease
Disease control Recruiting nowThe purpose of this study is to determine whether itacitinib is safe and effective in the treatment of systemic sclerosis in adults.
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Experimental virus vaccine takes on multiple cancers in early trial
Disease control Recruiting nowThis study is being conducted to explore the immunological mechanism of action of Peptide-coated Conditionally Replicating Adenovirus-1 (PeptiCRAd-1) plus Checkpoint inhibitor (CPI) therapy in multiple cancer types, as well as to obtain early information on the safety of this com…
Phase 1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hair lotion could boost hair growth in balding men
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of Finlândia hair lotion association in the treatment of androgenetic alopecia.
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Breathing battle: which oxygen method saves more lives after ICU extubation?
Disease control Recruiting nowIn intensive care units (ICUs), around 20% of patients experience respiratory failure after planned extubation. Nearly 40-50% of them eventually require reintubation with subsequently high mortality rates reaching 30-40%. NIV used as rescue therapy to treat post-extubation respir…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC